MALIGNANT NEOPLASMS OF INDEPENDENT (PRIMARY) MULTIPLE SITES
Clinical trials for MALIGNANT NEOPLASMS OF INDEPENDENT (PRIMARY) MULTIPLE SITES explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT NEOPLASMS OF INDEPENDENT (PRIMARY) MULTIPLE SITES trials appear
Sign up with your email to follow new studies for MALIGNANT NEOPLASMS OF INDEPENDENT (PRIMARY) MULTIPLE SITES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bacteria bombs target stubborn tumors in new cancer combo trial
Disease control OngoingThis study tests a special bacteria (Clostridium novyi-NT) injected directly into tumors, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors that haven't responded to standard treatments. The bacteria are designed to break down tumor cells f…
Matched conditions: MALIGNANT NEOPLASMS OF INDEPENDENT (PRIMARY) MULTIPLE SITES
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Do cancer patients and doctors see eye to eye on recovery?
Knowledge-focused OngoingThis study looks at whether cancer patients and their doctors have similar expectations about how well patients will perform daily activities after short-term inpatient rehabilitation. About 133 adults with cancer who can tolerate 3 hours of rehab per day will fill out questionna…
Matched conditions: MALIGNANT NEOPLASMS OF INDEPENDENT (PRIMARY) MULTIPLE SITES
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC